Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2010

Open Access 01-12-2010 | Research

Relationship between severe obesity and gut inflammation in children: what's next?

Authors: Maria Immacolata Spagnuolo, Maria Pia Cicalese, Maria Angela Caiazzo, Adriana Franzese, Veronica Squeglia, Luca Rosario Assante, Giuliana Valerio, Rossella Merone, Alfredo Guarino

Published in: Italian Journal of Pediatrics | Issue 1/2010

Login to get access

Abstract

Background

Preliminary evidence suggests an association between obesity and gut inflammation.

Aims

To evaluate the frequency of glucose abnormalities and their correlation with systemic and intestinal inflammation in severely obese children.

Patients and Methods

Thirty-four children (25 males; median age 10.8 ± 3.4 yrs) with severe obesity (BMI >95%) were screened for diabetes with oral glucose tolerance test (OGTT), systemic inflammation with C-reactive protein (CRP) and gut inflammation with rectal nitric oxide (NO) and faecal calprotectin.

Results

BMI ranged from 23 to 44 kg/m2, and BMI z-score between 2.08 e 4.93 (median 2.69 ± 0.53). Glucose abnormalities were documented in 71% of patients: type 2 diabetes in 29%, impaired fasting glucose (IFG) in 58%, and impaired glucose tolerance (IGT) in 37.5%. Thirty-one patients (91%) were hyperinsulinemic. CRP was increased in 73.5% with a correlation between BMI z-score and CRP (p 0.03). Faecal calprotectin was increased in 47% patients (mean 77 ± 68), and in 50% of children with abnormal glucose metabolism (mean 76 ± 68 μg/g), with a correlation with increasing BMI z-score. NO was pathological in 88%, and in 87.5% of glucose impairment (mean 6.8 ± 5 μM).

Conclusions

In this study, the prevalence of glucose abnormalities in obese children is higher than in other series; furthermore, a correlation is present between markers of systemic and intestinal inflammation and glucose abnormalities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Deckelbaum RJ, Williams CL: Childhood obesity: the health issue. Obes Rev. 2001, 9 (Suppl 4): 239s-243s.CrossRef Deckelbaum RJ, Williams CL: Childhood obesity: the health issue. Obes Rev. 2001, 9 (Suppl 4): 239s-243s.CrossRef
2.
go back to reference Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002, 288: 1728-1732. 10.1001/jama.288.14.1728.PubMedCrossRef Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002, 288: 1728-1732. 10.1001/jama.288.14.1728.PubMedCrossRef
3.
go back to reference Kopelman PG: Obesity as a medical problem. Nature. 2000, 404: 635-643.PubMed Kopelman PG: Obesity as a medical problem. Nature. 2000, 404: 635-643.PubMed
4.
go back to reference Pinhas-Hamiel O, Dolan LM, Daniels SR: Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr. 1996, 128: 608-615. 10.1016/S0022-3476(96)80124-7.PubMedCrossRef Pinhas-Hamiel O, Dolan LM, Daniels SR: Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr. 1996, 128: 608-615. 10.1016/S0022-3476(96)80124-7.PubMedCrossRef
5.
go back to reference Esteghamati A, Khalilzadeh O, Anvari M, Ahadi MS, Abbasi M, Rashidi A: Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass Index. Arch Med Res. 2008, 39 (8): 803-808. 10.1016/j.arcmed.2008.08.004.PubMedCrossRef Esteghamati A, Khalilzadeh O, Anvari M, Ahadi MS, Abbasi M, Rashidi A: Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass Index. Arch Med Res. 2008, 39 (8): 803-808. 10.1016/j.arcmed.2008.08.004.PubMedCrossRef
6.
go back to reference John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-1523. 10.1111/j.1365-2036.2006.02915.x.PubMedCrossRef John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-1523. 10.1111/j.1365-2036.2006.02915.x.PubMedCrossRef
7.
go back to reference John BJ, Abulafi AM, Poullis A, Mendall MA: Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people. Gut. 2007, 56: 1034-1035. 10.1136/gut.2007.125955.PubMedCentralPubMedCrossRef John BJ, Abulafi AM, Poullis A, Mendall MA: Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people. Gut. 2007, 56: 1034-1035. 10.1136/gut.2007.125955.PubMedCentralPubMedCrossRef
8.
go back to reference Yudkin JS: Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2003, 27: S25-S28. 10.1038/sj.ijo.0802496.PubMedCrossRef Yudkin JS: Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2003, 27: S25-S28. 10.1038/sj.ijo.0802496.PubMedCrossRef
9.
go back to reference Lyon CJ, Law RE, Hsueh WA: Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003, 144: 2195-2200. 10.1210/en.2003-0285.PubMedCrossRef Lyon CJ, Law RE, Hsueh WA: Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003, 144: 2195-2200. 10.1210/en.2003-0285.PubMedCrossRef
10.
go back to reference Robker RL, Collins RG, Beaudet AL, Mersmann HJ, Smith CW: Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res. 2004, 12: 936-940. 10.1038/oby.2004.114.PubMedCrossRef Robker RL, Collins RG, Beaudet AL, Mersmann HJ, Smith CW: Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res. 2004, 12: 936-940. 10.1038/oby.2004.114.PubMedCrossRef
11.
go back to reference Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralPubMedCrossRef Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralPubMedCrossRef
12.
go back to reference Bray GA: Medical consequences of obesity. J Clin Endocrinol Metab. 2004, 89: 2583-9. 10.1210/jc.2004-0535.PubMedCrossRef Bray GA: Medical consequences of obesity. J Clin Endocrinol Metab. 2004, 89: 2583-9. 10.1210/jc.2004-0535.PubMedCrossRef
13.
go back to reference Talley NJ, Howell S, Poulton R: Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004, 99: 1807-14. 10.1111/j.1572-0241.2004.30388.x.PubMedCrossRef Talley NJ, Howell S, Poulton R: Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004, 99: 1807-14. 10.1111/j.1572-0241.2004.30388.x.PubMedCrossRef
14.
go back to reference Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW: The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol. 2005, 3: 992-6. 10.1016/S1542-3565(05)00696-8.PubMedCrossRef Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW: The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol. 2005, 3: 992-6. 10.1016/S1542-3565(05)00696-8.PubMedCrossRef
15.
go back to reference Neal KR, Barker L, Spiller RC: Prognosis in post-infective irritable bowel syndrome: a six year follows up study. Gut. 2002, 51: 305-6. 10.1136/gut.51.3.410.CrossRef Neal KR, Barker L, Spiller RC: Prognosis in post-infective irritable bowel syndrome: a six year follows up study. Gut. 2002, 51: 305-6. 10.1136/gut.51.3.410.CrossRef
16.
go back to reference Tanner JM: Growth and adolescence. 1962, Oxford: Blackwell Scientific Publications, 2 Tanner JM: Growth and adolescence. 1962, Oxford: Blackwell Scientific Publications, 2
18.
go back to reference de Almeida CAN, Pinho AP, Ricco RG, Pepato MT, Brunetti IL: Glycemia, insulinemia and HOMA in children. Jornal de Pediatria. 2008, 84 (2): de Almeida CAN, Pinho AP, Ricco RG, Pepato MT, Brunetti IL: Glycemia, insulinemia and HOMA in children. Jornal de Pediatria. 2008, 84 (2):
19.
go back to reference d'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, the Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED): Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biom. 2009, 80: 21-28. d'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, the Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED): Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biom. 2009, 80: 21-28.
20.
go back to reference Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescence with marked obesity. N Engl J Med. 2002, 346 (11): 802-15. 10.1056/NEJMoa012578.PubMedCrossRef Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescence with marked obesity. N Engl J Med. 2002, 346 (11): 802-15. 10.1056/NEJMoa012578.PubMedCrossRef
21.
go back to reference American Diabetes Association: Screening for type 2 diabetes. Diabetes Care. 2004, 27 (Suppl 1): S11-S14. American Diabetes Association: Screening for type 2 diabetes. Diabetes Care. 2004, 27 (Suppl 1): S11-S14.
22.
go back to reference Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A: Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther. 2004, 20: 813-819. 10.1111/j.1365-2036.2004.02174.x.PubMedCrossRef Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A: Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther. 2004, 20: 813-819. 10.1111/j.1365-2036.2004.02174.x.PubMedCrossRef
23.
go back to reference Berni Canani R, Cirillo P, Bruzzese E, Graf M, Terrin G, Gaudiello G, De Curtis M, Cucchiara S, Guarino A: Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease. Am J Gastroenterol. 2002, 97: 1574-6. 10.1111/j.1572-0241.2002.05757.x.CrossRef Berni Canani R, Cirillo P, Bruzzese E, Graf M, Terrin G, Gaudiello G, De Curtis M, Cucchiara S, Guarino A: Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease. Am J Gastroenterol. 2002, 97: 1574-6. 10.1111/j.1572-0241.2002.05757.x.CrossRef
24.
go back to reference Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y: Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005, 40: 450-55. 10.1097/01.MPG.0000154657.08994.94.PubMedCrossRef Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y: Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005, 40: 450-55. 10.1097/01.MPG.0000154657.08994.94.PubMedCrossRef
25.
go back to reference Olafsdottir E, Aksnes L, Fluge G, Berstad A: Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr. 2002, 91: 45-50. 10.1080/080352502753457932.PubMedCrossRef Olafsdottir E, Aksnes L, Fluge G, Berstad A: Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr. 2002, 91: 45-50. 10.1080/080352502753457932.PubMedCrossRef
26.
go back to reference Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A: Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups. European Journal of Endocrinology. 2004, 151: 199-206. 10.1530/eje.0.1510199.PubMedCrossRef Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A: Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups. European Journal of Endocrinology. 2004, 151: 199-206. 10.1530/eje.0.1510199.PubMedCrossRef
27.
go back to reference Reaven GM, Chen YDI, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS: Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993, 76: 44-8. 10.1210/jc.76.1.44.PubMed Reaven GM, Chen YDI, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS: Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993, 76: 44-8. 10.1210/jc.76.1.44.PubMed
28.
go back to reference Shalitin S, Abrahami M, Lilos P, Phillip M: Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary care center in Israel. International Journal of Obesity. 2005, 29: 571-578. 10.1038/sj.ijo.0802919.PubMedCrossRef Shalitin S, Abrahami M, Lilos P, Phillip M: Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary care center in Israel. International Journal of Obesity. 2005, 29: 571-578. 10.1038/sj.ijo.0802919.PubMedCrossRef
29.
go back to reference Pradhan AD, Cook NR, Buring JE, Manson JAE, Ridker PM: C - Reactive Protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003, 23: 650-655. 10.1161/01.ATV.0000065636.15310.9C.PubMedCrossRef Pradhan AD, Cook NR, Buring JE, Manson JAE, Ridker PM: C - Reactive Protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003, 23: 650-655. 10.1161/01.ATV.0000065636.15310.9C.PubMedCrossRef
30.
go back to reference Sbarbati A, Osculati F, Silvagni D, Benati D, Galiè M, Camoglio FS, Rigotti G, Maffeis C: Obesity inflammation: evidence for an elementary lesion. Pediatrics. 2006, 117: 220-223. 10.1542/peds.2004-2854.PubMedCrossRef Sbarbati A, Osculati F, Silvagni D, Benati D, Galiè M, Camoglio FS, Rigotti G, Maffeis C: Obesity inflammation: evidence for an elementary lesion. Pediatrics. 2006, 117: 220-223. 10.1542/peds.2004-2854.PubMedCrossRef
Metadata
Title
Relationship between severe obesity and gut inflammation in children: what's next?
Authors
Maria Immacolata Spagnuolo
Maria Pia Cicalese
Maria Angela Caiazzo
Adriana Franzese
Veronica Squeglia
Luca Rosario Assante
Giuliana Valerio
Rossella Merone
Alfredo Guarino
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2010
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-36-66

Other articles of this Issue 1/2010

Italian Journal of Pediatrics 1/2010 Go to the issue